Yellow fever in a traveller returning from Suriname to the Netherlands, March 2017.
A Dutch traveller returning from Suriname in early March 2017, presented with fever and severe acute liver injury. Yellow fever was diagnosed by (q)RT-PCR and sequencing. During hospital stay, the patient's condition deteriorated and she developed hepatic encephalopathy requiring transfer to the intensive care. Although yellow fever has not been reported in the last four decades in Suriname, vaccination is recommended by the World Health Organization for visitors to this country.
University of Groningen, University Medical Center Groningen, Department of Internal Medicine / Infectious Diseases, Groningen, The Netherlands.|These authors contributed equally to this work.
Marjan
M
Wouthuyzen-Bakker
These authors contributed equally to this work.|University of Groningen, University Medical Center Groningen, Department of Medical Microbiology and Infection Prevention, Groningen, The Netherlands.
Marjolein
M
Knoester
University of Groningen, University Medical Center Groningen, Department of Gastroenterology & Hepatology, Groningen, The Netherlands.
Aad P
AP
van den Berg
Erasmus MC, Department of Viroscience, WHO Collaborating Centre for Arbovirus and Haemorrhagic Fever Reference and Research, Rotterdam, The Netherlands.
Corine H
CH
GeurtsvanKessel
Erasmus MC, Department of Viroscience, WHO Collaborating Centre for Arbovirus and Haemorrhagic Fever Reference and Research, Rotterdam, The Netherlands.
Marion Pg
MP
Koopmans
University of Groningen, University Medical Center Groningen, Department of Medical Microbiology and Infection Prevention, Groningen, The Netherlands.
Coretta
C
Van Leer-Buter
University of Groningen, University Medical Center Groningen, Department of Critical Care, Groningen, The Netherlands.
Bob
B
Oude Velthuis
Erasmus MC, Department of Viroscience, WHO Collaborating Centre for Arbovirus and Haemorrhagic Fever Reference and Research, Rotterdam, The Netherlands.
Suzan D
SD
Pas
National Coordination Centre for Communicable Disease Control, Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Wilhelmina Lm
WL
Ruijs
Bernhard Nocht Institute for Tropical Medicine, WHO Collaborating Centre for Arbovirus and Haemorrhagic Fever Reference and Research, Hamburg, Germany.|German Centre for Infection Research (DZIF), partner site Hamburg-Luebeck-Borstel, Hamburg, Germany.
Jonas
J
Schmidt-Chanasit
Academic Hospital Paramaribo, Department of Internal Medicine and Infectious Diseases, Paramaribo, Suriname.
Stephen Gs
SG
Vreden
University of Groningen, University Medical Center Groningen, Department of Internal Medicine / Infectious Diseases, Groningen, The Netherlands.
Tjip S
TS
van der Werf
Erasmus MC, Department of Viroscience, WHO Collaborating Centre for Arbovirus and Haemorrhagic Fever Reference and Research, Rotterdam, The Netherlands.
Chantal Bem
CB
Reusken
University of Groningen, University Medical Center Groningen, Department of Internal Medicine / Infectious Diseases, Groningen, The Netherlands.
Wouter Fw
WF
Bierman
D000328:Adult; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D004318:Doxycycline / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007299:Insect Bites and Stings; D007303:Insect Vectors / Q000821:virology*; D009426:Netherlands; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013532:Suriname; D014195:Travel; D016896:Treatment Outcome; D015004:Yellow Fever / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy; D015005:Yellow fever virus / Q000235:genetics / Q000302:isolation & purification*
D000900:Anti-Bacterial Agents; D004318:Doxycycline
Suriname; The Netherlands; clinic; laboratory; travel; vector-borne infections; viral infections; yellow fever; yellow fever virus